Flow cytometry and quantitative immunohistochemical study of cell cycle regulation proteins in invasive breast carcinoma
Authors:
- Françoise DuigouFDFrançoise Duigou
- Jacques MarnayJMJacques Marnay
- Michel Henry‐AmarMHMichel Henry‐Amar
- Jacques ChasleJCJacques Chasle
Open Access
Abstract
BACKGROUND: Between January 11, 1991 and January 8, 1992, 104 patients with previously untreated, invasive, primitive breast carcinoma were admitted to the authors' hospital.METHODS: For each patient, flow cytometry DNA analyses on frozen samples and on immunohistochemical staining were performed, including Ki‐67, cyclin A, p53, and p21waf1 (p21), with assessment of the percentages of positive nuclei were assessed. Correlations with classic clinicopathologic data and survival (overall, metastasis free, or recurrence free) and a multivariate analysis were performed.RESULTS: After a multivariate analysis according to a Cox model that was stratified by age, tumor size, tumor grade, lymph node status, and receptor status, among the factors studied, the presence of p21 was the unique remaining prognostic factor for patients with invasive breast carcinoma. Because of the lack of a correlation between p21 and proliferative factors (Ki‐67, S‐phase, and cyclin A), the authors combined p21 with those markers and found that, for the different combinations, after statistical analysis, only p21 combined with S‐phase or with cyclin A and lymph node status were salient survival prognostic factors.CONCLUSIONS: Immunohistochemical study of proteins involved in the cell cycle and assessment of proliferative activity using flow cytometric DNA analysis aided the authors in singling out correlations of cyclin A and S‐phase, along with p21, with metastasis free survival and overall survival in patients with invasive breast carcinoma. These promising results will require confirmation in a larger series of patients. Cancer 2003;97:1376–86. © 2003 American Cancer Society.DOI 10.1002/cncr.11209Keywords
This publication has 97 references indexed in Scilit:
- Flow cytometry in primary breast carcinomas. Prognostic impact of proliferative activityBreast Cancer Research and Treatment, 2000
- Prognostic Factors in Breast CancerArchives of Pathology & Laboratory Medicine, 2000
- Variation of flow cytometric DNA measurement in 1,485 primary breast carcinomas according to guidelines for DNA histogram interpretationCytometry, 2000
- 1997 update of recommendations for the use of tumor markers in breast and colorectal cancer. Adopted on November 7, 1997 by the American Society of Clinical Oncology.Journal of Clinical Oncology, 1998
- Cyclins, cyclin‐dependent kinases and differentiationBioEssays, 1997
- Clinical practice guidelines for the use of tumor markers in breast and colorectal cancer. Adopted on May 17, 1996 by the American Society of Clinical Oncology.Journal of Clinical Oncology, 1996
- Consensus review of the clinical utility of dna cytometry in carcinoma of the breastCytometry, 1993
- Localization of gene for human p53 tumour antigen to band 17p13Nature, 1986
- Characterization of a 54K Dalton cellular SV40 tumor antigen present in SV40-transformed cells and uninfected embryonal carcinoma cellsCell, 1979
- T antigen is bound to a host protein in SY40-transformed cellsNature, 1979